VIP enhances both pre‐ and postsynaptic GABAergic transmission to hippocampal interneurones leading to increased excitatory synaptic transmission to CA1 pyramidal cells
- 1 November 2004
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 143 (6) , 733-744
- https://doi.org/10.1038/sj.bjp.0705989
Abstract
Vasoactive intestinal peptide (VIP) is present in the hippocampus in three subtypes of GABAergic interneurones, two of which innervate preferentially other interneurones, responsible for pyramidal cell inhibition. We investigated how pre- and postsynaptic modulation of GABAergic transmission (to both pyramidal cells and interneurones) by VIP could influence excitatory synaptic transmission in the CA1 area of the hippocampus. VIP (0.1-100 nM) increased [(3)H]GABA release from hippocampal synaptosomes (maximum effect at 1 nM VIP; 63.8 +/- 4.0%) but did not change [(3)H]glutamate release. VIP (0.3-30 nM) enhanced synaptic transmission in hippocampal slices (maximum effect at 1 nM VIP; field excitatory postsynaptic potentials (epsp) slope: 23.7 +/- 1.1%; population spike amplitude: 20.3 +/- 1.7%). The action on field epsp slope was fully dependent on GABAergic transmission since it was absent in the presence of picrotoxin (50 microM) plus CGP55845 (1 microM). VIP (1 nM) did not change paired-pulse facilitation but increased paired-pulse inhibition in CA1 pyramidal cells (16.0 +/- 0.9%), reinforcing the involvement of GABAergic transmission in the action of VIP. VIP (1 nM) increased muscimol-evoked inhibitory currents by 36.4 +/- 8.7% in eight out of ten CA1 interneurones in the stratum radiatum. This suggests that VIP promotes increased inhibition of interneurones that control pyramidal cells, leading to disinhibition of synaptic transmission to pyramidal cell dendrites. In conclusion, concerted pre- and postsynaptic actions of VIP lead to disinhibition of pyramidal cell dendrites causing an enhancement of synaptic transmission.Keywords
This publication has 58 references indexed in Scilit:
- Serine 447 in the Carboxyl Tail of Human VPAC1 Receptor Is Crucial for Agonist-Induced Desensitization but Not Internalization of the ReceptorMolecular Pharmacology, 2003
- Inhibition by adenosine A2A receptors of NMDA but not AMPA currents in rat neostriatal neuronsBritish Journal of Pharmacology, 2000
- Vasoactive Intestinal Peptide (VIP)1 ReceptorPublished by Elsevier ,1996
- Differences between Somatic and Dendritic Inhibition in the HippocampusNeuron, 1996
- Adenosine A2a Receptor‐Mediated Modulation of Striatal [3H]GABA and [3H]Acetylcholine ReleaseJournal of Neurochemistry, 1994
- Short-Term Synaptic PlasticityAnnual Review of Neuroscience, 1989
- GABA-containing neurons in the septum control inhibitory interneurons in the hippocampusNature, 1988
- GABAB Receptor‐Mediated Enhancement of Vasoactive Intestinal Peptide‐Stimulated Cyclic AMP Production in Slices of Rat Cerebral CortexJournal of Neurochemistry, 1986
- Receptors for Vasoactive Intestinal Polypeptide on Isolated Synaptosomes from Rat Cerebral Cortex. Heterogeneity of Binding and Desensitization of ReceptorsJournal of Neurochemistry, 1982
- Recommended Methods for the Determination of Four Enzymes in BloodScandinavian Journal of Clinical and Laboratory Investigation, 1974